XML 15 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 34,219 $ 19,531
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization and depreciation 3,993 4,801
Restricted stock and stock option expense 3,923 3,111
Deferred federal income taxes 8,605 4,711
Amortization of bond premium and discount, net (16,989) (3,874)
Net realized investment losses (gains) (540) 2,414
Income from equity method investments, net of distributions 136 112
Changes in:    
Premium receivables, net 28,733 37,636
Reinsurance receivables, net 4,046 140
Funds held by ceding insurers (10,158) (1,076)
Unpaid losses and loss adjustment expenses (10,423) 29,399
Unearned premiums 510 (73,673)
Ceded balances payable (1,679) (13,709)
Other assets and liabilities 7,672 2,061
Contingent commissions (429) (4,015)
Federal income tax payable (2,657) 0
Deferred acquisition costs 1,590 18,952
Prepaid reinsurance premiums 1,698 10,231
Net cash provided by operating activities 52,250 36,752
Cash flows from investing activities:    
Proceeds from sale of fixed maturities 80,236 114,058
Proceeds from sale of equity securities 0 24
Proceeds from maturity of fixed maturities 539,542 158,216
Proceeds from maturity of preferred stock 5,534 500
Proceeds from other invested assets 8,641 1,196
Purchases of fixed maturities (682,546) (282,564)
Purchases of equity securities 0 (74)
Net cash used for investing activities (48,593) (8,644)
Cash flows from financing activities:    
Distributions paid to common shareholders (9,816) (7,477)
Distributions paid to preferred shareholders (330) (330)
Purchases of class A common shares (529) (12,677)
Net cash used for financing activities (10,675) (20,484)
Net change in cash and cash equivalents (7,018) 7,624
Cash and cash equivalents at beginning of period 38,037 38,846
Cash and cash equivalents at end of period $ 31,019 $ 46,470